Patient Group Directions

Applied filters

Patient Group Directions

Care Setting (13)
- Emergency medicine and urgent care (5)
- Occupational Health (6)
- Palliative and End of Life Care (1)
- Primary Care (1)
Events (1)
- Past Events (1)
Guidance (141)
- Administering (10)
- Dosing (2)
- Implementation (12)
- Medication Safety (1)
- Patient Group Directions (141)
- Policy, Commissioning and Managerial (8)
- Safety in Pregnancy (5)
- Service advice and planning (3)
- Supply (11)
- Unlicensed medicines (2)
Medicine (79)
- Aciclovir (2)
- Amoxicillin (1)
- Aspirin (1)
- Azithromycin (1)
- Benzylpenicillin (2)
- Ceftriaxone (1)
- Clarithromycin (5)
- Clotrimazole (2)
- Copper (1)
- Diamorphine (1)
- Diazepam (2)
- Doxycycline (2)
- Emtricitabine + Tenofovir disoproxil (1)
- Erythromycin (5)
- Estradiol + Dienogest (1)
- Estradiol + Nomegestrol (1)
- Ethinylestradiol + Desogestrel (1)
- Ethinylestradiol + Drospirenone (1)
- Ethinylestradiol + Etonogestrel (1)
- Ethinylestradiol + Gestodene (1)
- Ethinylestradiol + Levonorgestrel (1)
- Ethinylestradiol + Norelgestromin (1)
- Ethinylestradiol + Norethisterone (1)
- Ethinylestradiol + Norgestimate (1)
- Etonogestrel (2)
- Flucloxacillin (2)
- Fluconazole (1)
- Flumazenil (1)
- Fluticasone (1)
- Folic acid (1)
- Fusidic acid (1)
- Gadobutrol (1)
- Gadopiclenol (1)
- Gadoteric acid (1)
- Gadoteridol (1)
- Gadoxetic acid (1)
- Hydrogen peroxide (1)
- Imiquimod (1)
- Influenza vaccine (3)
- Iodixanol (1)
- Iohexol (1)
- Iomeprol (1)
- Iopamidol (1)
- Ioversol (1)
- Ketamine (1)
- Levonorgestrel (2)
- Lidocaine (5)
- Lidocaine + Prilocaine (1)
- Medroxyprogesterone (2)
- Meglumine gadobenate (1)
- Metronidazole (1)
- Midazolam (2)
- Mifepristone (1)
- Misoprostol (1)
- Mometasone (1)
- Morphine (1)
- Nitrofurantoin (1)
- Phenoxymethylpenicillin (2)
- Podophyllotoxin (1)
- Prilocaine (1)
- Progesterone (1)
- Raltegravir (1)
- Sodium chloride (1)
- Tenofovir disoproxil + Emtricitabine (1)
- Terbutaline (1)
- Tramadol (1)
- Tranexamic acid (1)
- Trimethoprim (1)
- Ulipristal (1)
- Valaciclovir (1)
- Varenicline (1)
Medicines planning (21)
- Patient Group Direction Planning (21)
Publications (95)
- Explainer videos (4)
- Research and audits (3)
- Summary advice (10)
- Templates (78)
Specialty (70)
- Infection and infectious diseases (26)
- Neurological disorders (1)
- Obstetrics and gynaecology (1)
- Public Health (1)
- Radiology (12)
- Renal and urologic disorders (2)
- Reproductive health (14)
- Respiratory disorders (13)
- Sexual health (12)
- Skin disorders (10)
- Smoking cessation (1)
- Vaccinating (3)
Training and Development (6)

Managing Patient Group Directions following amendments or changes

8 September 2020There are requirements for all PGDs to be resigned or reauthorised after any amendment or change made during its valid to/from dates

Use of PGDs by trainee registered healthcare professionals

8 September 2020Advice on the use of Patient Group Directions by registered healthcare professionals who are undertaking training and/or competency assessment

Patient Group Direction use in End of Life Care

10 August 2020Considerations required before implementing Patient Group Directions (PGDs) in End of Life Care.

PGD use in services provided by multiple organisations

14 July 2020Principles to be considered are outlined for Patient Group Directions used in the provision of medicines/vaccines in services provided by multiple organisations

Patient Specific Directions (PSD)

10 June 2020This article describes Patient Specific Directions and the requirements for their writing and use

Bank and agency staff and Patient Group Directions

25 February 2020The below summarises the advice on the use of PGDs by bank and agency staff working within organisations.

Off-label or unlicensed product use under HMR 2012 exemptions

8 January 2020A legal position summary regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the Human Medicines Regulations 2012

Patient Group Direction use in Primary Care Networks

8 January 2020Guidance on the legislation and governance required when considering the use of PGDs across a PCN

Medicines Shortages and Patient Group Directions

16 December 2019This article outlines how PGDs can be managed to allow for their continued use in cases of medicines shortages.

Using medicines under PGD as part of a clinical trial or study

26 June 2019Advice on the use of Patient Group Directions (PGDs) to supply or administer a medication which is part of a clinical trial, study or pilot

SPS - Specialist Pharmacy Service

NHS